You can:
Name | Neuromedin-K receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | TACR3 |
Synonym | SP-N receptor Tac3r Nmkr NKR NK3 receptor [ Show all ] |
Disease | Schizophrenia Schizophrenia; Schizoaffective disorders Psychotic disorders Psychiatric disorder Irritable bowel syndrome [ Show all ] |
Length | 465 |
Amino acid sequence | MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGLPVASPAPSQPWANLTNQFVQPSWRIALWSLAYGVVVAVAVLGNLIVIWIILAHKRMRTVTNYFLVNLAFSDASMAAFNTLVNFIYALHSEWYFGANYCRFQNFFPITAVFASIYSMTAIAVDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKTKVMPGRTLCFVQWPEGPKQHFTYHIIVIILVYCFPLLIMGITYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKMMIIVVMTFAICWLPYHIYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLNKRFRAGFKRAFRWCPFIKVSSYDELELKTTRFHPNRQSSMYTVTRMESMTVVFDPNDADTTRSSRKKRATPRDPSFNGCSRRNSKSASATSSFISSPYTSVDEYS |
UniProt | P29371 |
Protein Data Bank | N/A |
GPCR-HGmod model | P29371 |
3D structure model | This predicted structure model is from GPCR-EXP P29371. |
BioLiP | N/A |
Therapeutic Target Database | T29683 |
ChEMBL | CHEMBL4429 |
IUPHAR | 362 |
DrugBank | BE0002371 |
Name | Neurokinin B |
---|---|
Molecular formula | C55H79N13O14S2 |
IUPAC name | (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid |
Molecular weight | 1210.43 |
Hydrogen bond acceptor | 18 |
Hydrogen bond donor | 14 |
XlogP | -1.6 |
Synonyms | AKOS024456682 D07NNN (NKB)Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 BDBM50079412 Neurokinin B (human, porcine) [ Show all ] |
Inchi Key | NHXYSAFTNPANFK-HDMCBQFHSA-N |
Inchi ID | InChI=1S/C55H79N13O14S2/c1-30(2)21-38(50(77)62-36(47(57)74)17-19-83-5)61-43(69)28-59-55(82)46(31(3)4)68-54(81)40(23-33-15-11-8-12-16-33)65-51(78)39(22-32-13-9-7-10-14-32)64-53(80)42(26-45(72)73)67-52(79)41(24-34-27-58-29-60-34)66-49(76)37(18-20-84-6)63-48(75)35(56)25-44(70)71/h7-16,27,29-31,35-42,46H,17-26,28,56H2,1-6H3,(H2,57,74)(H,58,60)(H,59,82)(H,61,69)(H,62,77)(H,63,75)(H,64,80)(H,65,78)(H,66,76)(H,67,79)(H,68,81)(H,70,71)(H,72,73)/t35-,36-,37-,38-,39-,40-,41-,42-,46-/m0/s1 |
PubChem CID | 5311312 |
ChEMBL | CHEMBL437797 |
IUPHAR | 2090 |
BindingDB | 50079412 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 4.0 nM | PMID1312036, PMID2176308 | IUPHAR |
EC50 | 6.0 nM | PMID9871763 | BindingDB,ChEMBL |
IC50 | 2.0 nM | PMID8648606 | BindingDB |
IC50 | 3.0 nM | PMID9871763 | BindingDB,ChEMBL |
IC50 | 9.7 nM | PMID8648606 | ChEMBL |
IC50 | 10.0 nM | , Bioorg. Med. Chem. Lett., (1994) 4:14:1679, Bioorg. Med. Chem. Lett., (1995) 5:16:1773 | BindingDB,ChEMBL |
IC50 | 76.0 nM | PMID23473945 | BindingDB,ChEMBL |
Ki | 0.630957 - 19.9526 nM | PMID9190866, PMID11226387 | IUPHAR |
Ki | 0.7943 nM | PMID25738882 | ChEMBL |
Ki | 0.794328 nM | PMID25738882 | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417